Pancreatic Cancer Registry: For Any Person With a Personal or Family History

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT02886247
Status
Recruiting

Conditions

  • Pancreatic Cancer, ATM, BRCA, Hereditary Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The NFPTR was established in 1994 to find the causes of pancreatic cancer. In brief, the investigators are interested in both the genetic and non-genetic causes of pancreatic cancer. The investigators are particularly interested in finding the genes that cause pancreatic cancer to cluster in some families. Up to 10% of pancreatic cancer patients have another close relative who has also developed pancreatic cancer. This clustering of pancreatic cancers in families has yet to be explained; however, the investigators continue to identify new familial pancreatic cancer genes that explain this clustering in subsets of families. For example, in 2009 and 2012 the investigators discovered that mutations in the PALB2 and ATM genes jointly account up to 5% of the clustering of pancreatic cancer in families.

Key Dates

Start date
Jun 30, 1994
Status verified
Jul 2025
Primary completion
Jun 30, 2030
Completion
Dec 31, 2032

Study Design

Enrollment
12,000 participants (estimated)

Arms

  • Arm: participants
    individuals with a personal or family history of pancreas tumors

Primary Outcome Measure

pancreatic cancer [ Time Frame: 35 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Johns Hopkins HospitalBaltimoreMaryland21231
Alison Klein, PhD, MHS
410-955-3511

Find similar trials in Baltimore, MD